Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics (Q26799532)

Journal of Clinical Medicine

Europe PubMed Central

title

Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics (English)

0 references

0 references

1 reference

2

Emma Guttman-Yassky

0 references

author name string

Yasaman Mansouri

series ordinal

1

0 references

language of work or name

English

0 references

publication date

2015

0 references

published in

1 reference

Creative Commons Attribution 4.0 International

volume

4

0 references

issue

5

0 references

page(s)

858-73

0 references

copyright license

start time

29 April 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

The role of microorganisms in atopic dermatitis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

New era of biologic therapeutics in atopic dermatitis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Putting together the psoriasis puzzle: an update on developing targeted therapies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

New pathogenic and therapeutic paradigms in atopic dermatitis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

The translational revolution and use of biologics in patients with inflammatory skin diseases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Off-label prescriptions for atopic dermatitis in Europe

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

New insights into the allergic march

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Exome sequencing of filaggrin and related genes in African-American children with atopic dermatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Staphylococcus aureus Colonization in Acute and Chronic Skin Lesions of Patients with Atopic Dermatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

IL-17 targeted therapies for psoriasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

New insights into atopic dermatitis: role of skin barrier and immune dysregulation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Characterization of different courses of atopic dermatitis in adolescent and adult patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Atopic dermatitis in African American children: addressing unmet needs of a common disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

One remarkable molecule: filaggrin.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Filaggrin mutations associated with skin and allergic diseases.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Atopic dermatitis: a disease of altered skin barrier and immune dysregulation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Contrasting pathogenesis of atopic dermatitis and psoriasis--part I: clinical and pathologic concepts

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Atopic dermatitis - from new pathophysiologic insights to individualized therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Extrinsic and intrinsic types of atopic dermatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Pathogenesis of atopic dermatitis: new developments

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Abnormal skin barrier in the etiopathogenesis of atopic dermatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

"Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Clinical differences between atopic and atopiform dermatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Pharmacokinetics of immunosuppressants: a perspective on ethnic differences.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Allergic and nonallergic forms of atopic diseases

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Epidemiology, clinical features, and immunology of the "intrinsic" (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

In vivo evaluation of the stratum corneum barrier function in blacks, Caucasians and Asians with two noninvasive methods.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Immunologic effects of omalizumab in children with severe refractory atopic dermatitis: a randomized, placebo-controlled clinical trial

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Ethnicity and stratum corneum ceramides.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Quality of life in atopic dermatitis.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

London-born black Caribbean children are at increased risk of atopic dermatitis.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Atopic dermatitis: a candidate for disease-modifying strategy

31 May 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

Novel filaggrin mutation but no other loss-of-function variants found in Ethiopian patients with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

Severity scores, itch scores and plasma substance P levels in atopic dermatitis treated with standard topical therapy with oral olopatadine hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: results of a randomized, vehicle-controlled, multicenter clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

Efficacy and safety of adalimumab among patients with moderate to severe psoriasis with co-morbidities: Subanalysis of results from a randomized, double-blind, placebo-controlled, phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

Systemic treatment of pediatric atopic dermatitis with azathioprine and mycophenolate mofetil.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

Residual genomic signature of atopic dermatitis despite clinical resolution with narrow-band UVB.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs. extrinsic atopic dermatitis patients using semiquantitative RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

Characteristics of extrinsic vs. intrinsic atopic dermatitis in infancy: correlations with laboratory variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

Distribution of IL-31 and its receptor expressing cells in skin of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

In vitro transepidermal water loss: differences between black and white human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

In the United States, blacks and Asian/Pacific Islanders are more likely than whites to seek medical care for atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

Central obesity and high blood pressure in pediatric patients with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

Morbidity and cost of atopic eczema in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

A randomized trial of methotrexate vs. azathioprine for severe atopic eczema: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FJCM4050858

The cost of atopic eczema.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4470203

Correlation of IL-31 serum levels with severity of atopic dermatitis

28 November 2018

1 reference

12 December 2020

Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis

1 reference

12 December 2020

Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial

1 reference

12 December 2020

1 reference

12 December 2020

Dichotomic nature of atopic dermatitis reflected by combined analysis of monocyte immunophenotyping and single nucleotide polymorphisms of the interleukin-4/interleukin-13 receptor gene: the dichotomy of extrinsic and intrinsic atopic dermatitis

1 reference

12 December 2020

In vivo expression of IL-12 and IL-13 in atopic dermatitis

1 reference

12 December 2020

Decrease in circulating Th17 cells correlates with increased levels of CCL17, IgE and eosinophils in atopic dermatitis

1 reference

12 December 2020

Thiopurine methyltransferase activity in American white subjects and black subjects

1 reference

12 December 2020

Dupilumab treatment in adults with moderate-to-severe atopic dermatitis

1 reference

12 December 2020

Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis

1 reference

12 December 2020

Cyclosporine therapy for severe atopic dermatitis

1 reference

12 December 2020

A group of atopic dermatitis without IgE elevation or barrier impairment shows a high Th1 frequency: possible immunological state of the intrinsic type

1 reference

12 December 2020

The financial impact on families of children with atopic dermatitis

1 reference

12 December 2020

Delayed eosinophil programmed cell death in vitro: a common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis

1 reference

12 December 2020

Immunological differences between intrinsic and extrinsic types of atopic dermatitis

1 reference

12 December 2020

1 reference

12 December 2020

Effects of cyclosporine on pruritus and serum IL-31 levels in patients with atopic dermatitis

1 reference

12 December 2020

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group

1 reference

12 December 2020

Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients

1 reference

12 December 2020

Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial

1 reference

12 December 2020

Identifiers

DOI

10.3390/JCM4050858

1 reference

release_2y3egcjh3bcllbtyh5my45metq

1459451

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2y3egcjh3bcllbtyh5my45metq

24 November 2022

mapped directly with Wikidata item

1459451

1 reference

1 reference

1 reference